Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Drug Failure”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT06285110
What this trial is testing

HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen

Who this might be right for
Hiv
University of Bern 1,103
Testing effectiveness (Phase 2)Looking for participantsNCT05732051
What this trial is testing

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac Dysfunction+2 more
University Hospital, Akershus 60
Large-scale testing (Phase 3)Study completedNCT00042653
What this trial is testing

An Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Amgen 380
Not applicableStudy completedNCT01014065
What this trial is testing

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)

Who this might be right for
Renal Cell CarcinomaCardiotoxicityHeart Failure+1 more
AHS Cancer Control Alberta 42
Post-approval studies (Phase 4)Study completedNCT00609856
What this trial is testing

Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesSecondary Drug Failure
Skane University Hospital 36
Testing effectiveness (Phase 2)Ended earlyNCT00006121
What this trial is testing

Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 18
Testing effectiveness (Phase 2)Ended earlyNCT00452140
What this trial is testing

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment

Who this might be right for
Metastatic Breast CancerAdvanced Breast Cancer
Neovii Biotech 40
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Large-scale testing (Phase 3)Study completedNCT00037635
What this trial is testing

An Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
Amgen 400
Not applicableStudy completedNCT01801618
What this trial is testing

National Evaluation of PI-based 2nd Line Efficacy in Cambodia

Who this might be right for
HIV
ANRS, Emerging Infectious Diseases 15,001,351
Not applicableStudy completedNCT06268535
What this trial is testing

Identification of Anticancer Drugs Associated With Cancer Therapy-related Cardiac Dysfunction: a Pharmacovigilance Study

Who this might be right for
Heart FailureCancer, Therapy-Related
University Hospital, Caen 36,580,288
Not applicableUnknownNCT06661317
What this trial is testing

Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.

Who this might be right for
HIV-1-infectionDRMDRM Gene Mutation+1 more
Medical University of Warsaw 200
Testing effectiveness (Phase 2)Study completedNCT00221650
What this trial is testing

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected Patients

Who this might be right for
HIV InfectionsHepatitis C, ChronicTreatment Failure
University Hospital, Bordeaux 17
Not applicableUnknownNCT04781699
What this trial is testing

Optimising Secondary Prevention and Quality of Life in Early Cardiac Rehabilitation

Who this might be right for
Cardiovascular DiseasesCoronary Artery DiseaseMyocardial Infarction+3 more
Sheffield Hallam University 498
Not applicableEnded earlyNCT01540227
What this trial is testing

Penicillin Therapeutic Drug Monitoring in the Treatment of Infectious Syphilis.

Who this might be right for
SyphilisPrimary SyphilisSecondary Syphilis+1 more
Ottawa Hospital Research Institute 25
Not applicableUnknownNCT05880160
What this trial is testing

Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction

Who this might be right for
CardiotoxicityHER2-positive Breast CancerHeart Failure+1 more
University College, London 90
Testing effectiveness (Phase 2)Study completedNCT01715441
What this trial is testing

Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors

Who this might be right for
Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
Institut du Cancer de Montpellier - Val d'Aurelle 173
Not applicableStudy completedNCT01788891
What this trial is testing

Second-line Therapy

Who this might be right for
Treatment Failure of Second-line ART in Asian HIV-infected Children
The HIV Netherlands Australia Thailand Research Collaboration 300
Testing effectiveness (Phase 2)Study completedNCT00110929
What this trial is testing

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

Who this might be right for
End Stage Renal Disease
Amgen 850
Next Page